Bettina Cockroft
Director/Board Member at ANNEXON, INC.
Net worth: - $ as of 30/04/2024
Bettina Cockroft active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ANNEXON, INC. | Director/Board Member | 20/01/2022 | - |
| Independent Dir/Board Member | 20/01/2022 | - | |
| CNS PHARMACEUTICALS, INC. | Director/Board Member | 08/05/2023 | - |
| Independent Dir/Board Member | 08/05/2023 | - | |
| Annexon Biosciences, Inc. | Director/Board Member | - | - |
Career history of Bettina Cockroft
Former positions of Bettina Cockroft
| Companies | Position | Start | End |
|---|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 30/09/2019 | 16/05/2023 |
| CYTOKINETICS, INCORPORATED | Corporate Officer/Principal | 01/08/2017 | 01/09/2019 |
Auris Medical AG
 Auris Medical AG Medical SpecialtiesHealth Technology Auris Medical AG manufactures electronic devices for ear disorders. It develops novel pharmaceutical therapies to protect hearing and to silence tinnitus. The company was founded by Thomas Meyer in April 2003 and is headquartered in Basel, Switzerland. | Chief Tech/Sci/R&D Officer | 01/09/2013 | 01/09/2016 |
Training of Bettina Cockroft
| MIT Sloan School of Management | Masters Business Admin |
| University of Genoa | Doctorate Degree |
Statistics
International
| United States | 7 |
| Italy | 2 |
| Switzerland | 2 |
Operational
| Director/Board Member | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
| Independent Dir/Board Member | 2 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 4 |
|---|---|
| CYTOKINETICS, INCORPORATED | Health Technology |
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| ANNEXON, INC. | Health Technology |
| CNS PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Auris Medical AG
Auris Medical AG Medical SpecialtiesHealth Technology Auris Medical AG manufactures electronic devices for ear disorders. It develops novel pharmaceutical therapies to protect hearing and to silence tinnitus. The company was founded by Thomas Meyer in April 2003 and is headquartered in Basel, Switzerland. | Health Technology |
| Annexon Biosciences, Inc. |
- Stock Market
- Insiders
- Bettina Cockroft
- Experience
